Brokerage firm Goldman Sachs has initiated coverage on two hospital stocks with bullish views, placing both Max Healthcare and Krishna Institute of Medical Sciences (KIMS) firmly on its radar.

The brokerage began coverage on Max Healthcare with a 'Buy' rating and a price target of ₹1,325, signalling a potential upside of about 20% from current levels.

Goldman cited Max's strong growth trajectory, projecting 23% revenue and 24% EBITDA CAGRs over FY25 to FY28, driven largely by bed expansions.

It also mentioned about the company's industry-leading profitability metrics led by operational efficiencies, along with the strongest balance sheet and free cash flow profile in the sector, giving Max the highest capacity expansion potential among peers.

Goldman Sachs has also initiated coverage o

See Full Page